Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ARTELO BIOSCIENCES, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Armistice Capital, LLC (filed 2026-05-15).
Who is behind it
ARTELO BIOSCIENCES, INC.: incorporated in Nevada; business address in Solana Beach, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- Gregory D. Gorgas: Executive Officer, Director (Form D, 2026-04-06)
- Connie Matsui: Director (Form D, 2026-04-06)
- Douglas Blayney: Director (Form D, 2026-04-06)
- Steven Kelly: Director (Form D, 2026-04-06)
- R. Martin Emanuele: Director (Form D, 2026-04-06)
- Tamara A. Favorito: Director (Form D, 2026-04-06)
- Gregory R. Reyes: Director (Form D, 2026-04-06)
- Mark Spring: Executive Officer (Form D, 2026-04-06)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Armistice Capital, LLC | 0% |
| Schedule 13G/A, 2026-08-13 | Mitchell P. Kopin | 4.8% |
| Schedule 13G, 2026-05-15 | Armistice Capital, LLC | 9.99% |
| Schedule 13G, 2026-04-03 | Mitchell P. Kopin | 9.99% |
| Schedule 13D/A, 2025-10-21 | Farb Daniel Stuart | 0.8% |
| Schedule 13D/A, 2025-10-17 | Farb Daniel Stuart | 7.7% |
| Schedule 13D/A, 2025-10-03 | Farb Daniel Stuart | 7.7% |
| Schedule 13D, 2025-09-19 | Farb Daniel Stuart | 9.8% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-04-06 | $11M | $11M |
| Form D, 2026-03-27 | $315K | $315K |
| Form D, 2026-03-27 | $237K | $237K |
| Form D, 2026-03-27 | $113K | $113K |
| Form D, 2026-02-06 | $500K | $50.50M |
| Form D, 2025-11-10 | $3.72M | $3.72M |
| Form D, 2025-08-13 | $9.47M | $9.47M |
| Form D, 2025-07-09 | $1.43M | $1.43M |
Latest IPO step: ARTELO BIOSCIENCES, INC. filed to go public (S-1, 2026-04-07).
IPO filings: S-1, 2026-04-07, RW, 2026-03-27, S-1, 2026-03-24, S-1/A, 2026-03-24, S-1/A, 2026-03-23; ticker ARTL on Nasdaq Capital Market.
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/artelo-biosciences-inc